AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9471044 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral bladder neck incision
Number of subjects: 73
Study 7635581 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-Hz EEG measures during preinduction resting conditions
Number of subjects: 41
Study 7635581 — intervention group
Group type: EXPERIMENTAL
Intervention: N1 amplitudes recorded during hypnosis
Number of subjects: 41
Study 7635581 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression analysis
Number of subjects: 41
Study 2694857 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Midazolam (0.3 mg/kg bw)
Number of subjects: 60
Study 2694857 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal Midazolam (0.5 mg/kg bw)
Number of subjects: 60
Study 7373 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 25 mg three times daily for 1 week, then 100 mg three times daily for 5 weeks
Number of subjects: 16
Study 7373 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 16
Study 7373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31683110 — intervention group
Group type: EXPERIMENTAL
Intervention: Agricultural interventions with behavior change communication strategies (village health committees or older female leaders)
Number of subjects: 0
Study 31568009 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg of methylprednisolone twice daily for 5 days
Number of subjects: 0
Study 31568009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28338229 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised moderate-intensity endurance exercise training for 16 weeks
Number of subjects: 48
Study 25187393 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-axis shoulder abduction splint
Number of subjects: 24
Study 25187393 — intervention group
Group type: COMPARATOR
Intervention: Control (unsplinted)
Number of subjects: 24
Study 23433098 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent/smoker role conflict (measured by agreement with the statement about smoking interfering with parenting)
Number of subjects: 1980
Study 23433098 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent/smoker role conflict
Number of subjects: 1980
Study 23433098 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning to quit smoking in the next 30 days
Number of subjects: 1980
Study 21474024 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar recruitment maneuver (ARM) with positive end expiratory pressure of 30 cmH₂O and inspiratory plateau pressure of 45 cmH₂O for 2 minutes after pneumoperitoneum deflation
Number of subjects: 30
Study 21474024 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study 18637615 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil-Ketamine group (remifentanil 0.2 microg/kg/min + ketamine 1 microg/kg/min)
Number of subjects: 32
Study 18637615 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil-Ketamine group
Number of subjects: 32
Study 18637615 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil group (remifentanil 0.2 microg/kg/min)
Number of subjects: 32
Study 18637615 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil group
Number of subjects: 32
Study 17060763 — intervention group
Group type: COMPARATOR
Intervention: Postoperative enteral feeding with synbiotics (group A)
Number of subjects: 101
Study 17060763 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative plus postoperative synbiotics (group B)
Number of subjects: 101
Study 15001641 — intervention group
Group type: EXPERIMENTAL
Intervention: Urocortin-1 infusion (50 micro g iv over 1 h)
Number of subjects: 8
Study 11711841 — intervention group
Group type: EXPERIMENTAL
Intervention: Travoprost 0.004%
Number of subjects: 573
Study 11711841 — intervention group
Group type: EXPERIMENTAL
Intervention: Travoprost 0.0015%
Number of subjects: 573
Study 11711841 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 573
Study 9386070 — intervention group
Group type: EXPERIMENTAL
Intervention: Reoperative CABG (EF <36%)
Number of subjects: 1429
Study 9386070 — intervention group
Group type: COMPARATOR
Intervention: Primary CABG (EF <36%)
Number of subjects: 1429
Study 9386070 — intervention group
Group type: EXPERIMENTAL
Intervention: Reoperative CABG (EF <25%)
Number of subjects: 1429
Study 9386070 — intervention group
Group type: COMPARATOR
Intervention: Primary CABG (EF <25%)
Number of subjects: 1429
Study 9386070 — intervention group
Group type: EXPERIMENTAL
Intervention: Reoperative CABG (EF <25% vs 25% to 35%)
Number of subjects: 1429
Study 9386070 — intervention group
Group type: EXPERIMENTAL
Intervention: Reoperative CABG
Number of subjects: 1429
Study 7523776 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg orally daily
Number of subjects: 9
Study 7523776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 3232776 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone (5 mg/kg) followed by suxamethonium (1.5 mg/kg)
Number of subjects: 30
Study 3232776 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium (0.5 mg/kg) followed by thiopentone (5 mg/kg)
Number of subjects: 30
Study 28882740 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-deprived state (after a night shift duty)
Number of subjects: 48
Study 28882740 — intervention group
Group type: COMPARATOR
Intervention: Control state (after a night of sleep)
Number of subjects: 48
Study 28874177 — intervention group
Group type: EXPERIMENTAL
Intervention: SELEVER intervention group
Number of subjects: 120
Study 28874177 — intervention group
Group type: EXPERIMENTAL
Intervention: SELEVER with an intensive WASH component
Number of subjects: 120
Study 28874177 — intervention group
Group type: COMPARATOR
Intervention: Control group without intervention
Number of subjects: 120
Study 24308798 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly peer-based social skills training
Number of subjects: 207
Study 24308798 — intervention group
Group type: COMPARATOR
Intervention: Universal social-emotional curriculum
Number of subjects: 207
Study 23875866 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuum of Care for Frail Older People
Number of subjects: 161
Study 23875866 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 161
Study 20929988 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacists added to primary care teams
Number of subjects: 260
Study 18812476 — intervention group
Group type: EXPERIMENTAL
Intervention: Albiglutide 32 mg
Number of subjects: 100
Study 18812476 — intervention group
Group type: EXPERIMENTAL
Intervention: Albiglutide (16 or 64 mg)
Number of subjects: 100
Study 18812476 — intervention group
Group type: EXPERIMENTAL
Intervention: Albiglutide
Number of subjects: 100
Study 17161781 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped waveform
Number of subjects: 20
Study 17161781 — intervention group
Group type: COMPARATOR
Intervention: 50/50% tilt biphasic
Number of subjects: 20
Study 14760437 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity and cardiorespiratory fitness assessment
Number of subjects: 385
Study 14760437 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up blood pressure measurements
Number of subjects: 385
Study 10627329 — intervention group
Group type: COMPARATOR
Intervention: Normal children
Number of subjects: 40
Study 10627329 — intervention group
Group type: EXPERIMENTAL
Intervention: Spastic children
Number of subjects: 40
Study 9186882 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary protein restriction
Number of subjects: 840
Study 9186882 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict blood pressure control
Number of subjects: 840
Study 9186882 — intervention group
Group type: COMPARATOR
Intervention: Baseline factors
Number of subjects: 840
Study 8255512 — intervention group
Group type: EXPERIMENTAL
Intervention: Benazepril (20 mg o.d.)
Number of subjects: 13
Study 8255512 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (200 mg o.d.) and Chlorthalidone (25 mg o.d.)
Number of subjects: 13
Study 3545685 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g per day)
Number of subjects: 17
Study 3545685 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (300 mg per day)
Number of subjects: 17
Study 28439790 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified NIATx Process Improvement Strategy
Number of subjects: 14
Study 27745551 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) plus deferoxamine (DFX)
Number of subjects: 80
Study 27745551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 24652467 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab therapy (500 mg or 1000 mg infusions on study days 1 and 15)
Number of subjects: 10
Study 24652467 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab therapy
Number of subjects: 10
Study 24652467 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab therapy with oral corticosteroids during infusion
Number of subjects: 10
Study 23566945 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM197 (primary immunisation)
Number of subjects: 0
Study 23566945 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM197 (before booster immunisation)
Number of subjects: 0
Study 23566945 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM197 (one month after booster immunisation)
Number of subjects: 0
Study 23566945 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM197 (correlation with antibody persistence)
Number of subjects: 0
Study 19966539 — intervention group
Group type: EXPERIMENTAL
Intervention: Active vaccination program (educational program to promote vaccination)
Number of subjects: 3646
Study 19966539 — intervention group
Group type: COMPARATOR
Intervention: No action (control group)
Number of subjects: 3646
Study 18197842 — intervention group
Group type: EXPERIMENTAL
Intervention: Early loaded dental implants (n=16)
Number of subjects: 15
Study 18197842 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed loaded dental implants (n=14)
Number of subjects: 15
Study 18197842 — intervention group
Group type: EXPERIMENTAL
Intervention: All dental implants
Number of subjects: 15
Study 15683898 — intervention group
Group type: EXPERIMENTAL
Intervention: Etching with phosphoric acid for 60s
Number of subjects: 80
Study 15683898 — intervention group
Group type: COMPARATOR
Intervention: Etching with phosphoric acid for 40s
Number of subjects: 80
Study 15683898 — intervention group
Group type: COMPARATOR
Intervention: Etching with phosphoric acid for 20s plus Xeno III (20s)
Number of subjects: 80
Study 15683898 — intervention group
Group type: COMPARATOR
Intervention: Etching with phosphoric acid for 40s plus Xeno III (20s)
Number of subjects: 80
Study 12501967 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing with cognitive change or exposure instructions (20 minutes on 4 days over 2 weeks)
Number of subjects: 121
Study 12501967 — intervention group
Group type: COMPARATOR
Intervention: Writing about innocuous topics (control group)
Number of subjects: 121
Study 12501967 — intervention group
Group type: EXPERIMENTAL
Intervention: All subjects (combined group)
Number of subjects: 121
Study 10029963 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.005 mg/kg
Number of subjects: 30
Study 10029963 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.015 mg/kg
Number of subjects: 30
Study 10029963 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.030 mg/kg
Number of subjects: 30
Study 7728861 — intervention group
Group type: EXPERIMENTAL
Intervention: Three methods of femoral artery hemostasis
Number of subjects: 503
Study 7728861 — intervention group
Group type: EXPERIMENTAL
Intervention: Restarting heparin postsheath removal
Number of subjects: 503
Study 7728861 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of procedures done during one hospitalization
Number of subjects: 503
Study 7728861 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncompliance of the patient with bedrest after the procedure
Number of subjects: 503
Study 7728861 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of arterial punctures to initiate the procedure
Number of subjects: 503
Study 7728861 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedure treatment with corticosteroids
Number of subjects: 503
Study 2137218 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/day (group 1, n = 68)
Number of subjects: 136
Study 2137218 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine 40 mg/day (group II, n = 68)
Number of subjects: 136
Study 534846 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of the testicular veins
Number of subjects: 96
Study 534846 — intervention group
Group type: COMPARATOR
Intervention: Control group (no surgery)
Number of subjects: 96
Study 30637626 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2798745 (TRPV4 channel blocker)
Number of subjects: 0
Study 30637626 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2798745 (TRPV4 channel blocker) with high-fat meal
Number of subjects: 0
Study 28471254 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help manual
Number of subjects: 0
Study 28471254 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 24029724 — intervention group
Group type: COMPARATOR
Intervention: General trunk exercise programme (n=32)
Number of subjects: 61
Study 24029724 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific trunk exercise programme (n=29)
Number of subjects: 61
Study 25457738 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-referenced aIAT version
Number of subjects: 41
Study 25457738 — intervention group
Group type: COMPARATOR
Intervention: 'Guilty/innocent' aIAT version
Number of subjects: 41
Study 25457738 — intervention group
Group type: EXPERIMENTAL
Intervention: aIAT outcomes
Number of subjects: 41
Study 22971278 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil combined with Anluohuaxian capsule for 48 weeks
Number of subjects: 72
Study 22971278 — intervention group
Group type: COMPARATOR
Intervention: Adefovir dipivoxil (ADV)
Number of subjects: 72
Study 19439433 — intervention group
Group type: EXPERIMENTAL
Intervention: Splint group (n = 33)
Number of subjects: 54
Study 19439433 — intervention group
Group type: COMPARATOR
Intervention: No-splint group (n = 36)
Number of subjects: 54
Study 18004477 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal connective tissue graft
Number of subjects: 22
Study 18004477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM) graft
Number of subjects: 22
Study 18004477 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 22
Study 11908355 — intervention group
Group type: EXPERIMENTAL
Intervention: New dentifrice containing 5.0% potassium nitrate and 0.454% stannous fluoride in a silica base (Colgate Sensitive Maximum Strength Toothpaste)
Number of subjects: 109
Study 11908355 — intervention group
Group type: COMPARATOR
Intervention: Commercially available desensitizing dentifrice containing 5.0% potassium nitrate and 0.243% sodium fluoride in a silica base (Sensodyne Fresh Mint Toothpaste)
Number of subjects: 109
Study 11908355 — intervention group
Group type: COMPARATOR
Intervention: Nondesensitizing dentifrice containing 0.243% sodium fluoride in a silica base (Colgate Winterfresh Gel)
Number of subjects: 109
Study 8821519 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of diclofenac and codeine phosphate (50 mg each)
Number of subjects: 12
Study 8821519 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal administration of diclofenac and codeine phosphate (50 mg each)
Number of subjects: 12
Study 8821519 — intervention group
Group type: COMPARATOR
Intervention: Suppositories (rectal)
Number of subjects: 12
Study 1573749 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 42
Study 1573749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 3936198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil alone
Number of subjects: 184
Study 3936198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil and probenecid
Number of subjects: 184
Study 3936198 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin plus probenecid
Number of subjects: 184
Study 31010315 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment via Facebook
Number of subjects: 138
Study 31010315 — intervention group
Group type: COMPARATOR
Intervention: Recruitment via Twitter or Instagram
Number of subjects: 138
Study 31010315 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recruitment via social media
Number of subjects: 138
Study 31010315 — intervention group
Group type: EXPERIMENTAL
Intervention: Social media recruitment
Number of subjects: 138
Study 28778455 — intervention group
Group type: EXPERIMENTAL
Intervention: rush oral immunotherapy (rOIT) for 3 months
Number of subjects: 45
Study 28778455 — intervention group
Group type: COMPARATOR
Intervention: egg elimination diet (control)
Number of subjects: 45
Study 28778455 — intervention group
Group type: EXPERIMENTAL
Intervention: rush oral immunotherapy (rOIT) for 12 months
Number of subjects: 45
Study 27238752 — intervention group
Group type: EXPERIMENTAL
Intervention: PegIFN (180μg/week) for 24 weeks followed by 24 weeks for early responders (arm A)
Number of subjects: 0
Study 27238752 — intervention group
Group type: COMPARATOR
Intervention: PegIFN for another 24 weeks (arm B)
Number of subjects: 0
Study 27238752 — intervention group
Group type: COMPARATOR
Intervention: PegIFN for another 72 weeks (arm C)
Number of subjects: 0
Study 27238752 — intervention group
Group type: COMPARATOR
Intervention: PegIFN for another 72 weeks plus adefovir for 36 weeks (arm D)
Number of subjects: 0
Study 27238752 — intervention group
Group type: COMPARATOR
Intervention: PegIFN for 48 weeks (control group)
Number of subjects: 0
Study 25533009 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral L-carnitine (20 mg/kg/day) for 12 months
Number of subjects: 176
Study 25533009 — intervention group
Group type: COMPARATOR
Intervention: Control group (no L-carnitine supplementation)
Number of subjects: 176
Study 22757655 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,800 mg G-GR
Number of subjects: 549
Study 22757655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 549
Study 21076630 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive lipid targets (LDL-C ≤ 70 mg/dL, non-HDL-C ≤ 100 mg/dL)
Number of subjects: 499
Study 21076630 — intervention group
Group type: COMPARATOR
Intervention: Standard lipid targets (LDL-C ≤ 100 mg/dL, non-HDL-C ≤ 130 mg/dL)
Number of subjects: 499
Study 18760163 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable fastening brace
Number of subjects: 15
Study 18760163 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression garment
Number of subjects: 15
Study 18760163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports tape
Number of subjects: 15
Study 18760163 — intervention group
Group type: COMPARATOR
Intervention: No support
Number of subjects: 15
Study 15721120 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol dose of 1 to 2 ml
Number of subjects: 42
Study 15721120 — intervention group
Group type: COMPARATOR
Intervention: Ethanol dose of >2 ml
Number of subjects: 42
Study 12642173 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (25 mg intravenously)
Number of subjects: 11
Study 12642173 — intervention group
Group type: COMPARATOR
Intervention: No pharmacological challenge (control)
Number of subjects: 11
Study 10333775 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietitian-delivered nutrition counseling (2 individual and 2 group sessions over 6 weeks)
Number of subjects: 645
Study 8942335 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium (group Roc)
Number of subjects: 56
Study 8942335 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (group Vec)
Number of subjects: 56
Study 8942335 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium (group Atr)
Number of subjects: 56
Study 8942335 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium (group Pan)
Number of subjects: 56
Study 1758526 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTx) in secondary hyperparathyroidism (group I)
Number of subjects: 42
Study 1758526 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTx) in primary hyperparathyroidism (group II)
Number of subjects: 42
Study 1758526 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (1 microgram/day) in chronic dialysis patients (group IV)
Number of subjects: 42
Study 1758526 — intervention group
Group type: COMPARATOR
Intervention: Placebo in chronic dialysis patients (group IV)
Number of subjects: 42
Study 1758526 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTx) in cervicotomy patients (group III)
Number of subjects: 42
Study 31670491 — intervention group
Group type: EXPERIMENTAL
Intervention: ProGlide
Number of subjects: 1987
Study 31670491 — intervention group
Group type: COMPARATOR
Intervention: Prostar
Number of subjects: 1987
Study 29506566 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic inguinal ligament suspension (LILS)
Number of subjects: 107
Study 29506566 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic sacrocolpopexy (LSC)
Number of subjects: 107
Study 26986459 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (paclitaxel 200 mg/m² and carboplatin AUC 5) followed by external radiotherapy (60 Gy/30 fractions/6 weeks)
Number of subjects: 36
Study 26986459 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (paclitaxel 200 mg/m² and carboplatin AUC 5) followed by accelerated hypofractionated radiotherapy (AHFx‐RT) (48 Gy/20 fractions/4 weeks) with concomitant chemotherapy (cisplatin 30 mg/m² weekly)
Number of subjects: 36
Study 24438894 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) intervention
Number of subjects: 180
Study 22510183 — intervention group
Group type: EXPERIMENTAL
Intervention: SABER‐Bupivacaine 5.0 mL (660 mg)
Number of subjects: 124
Study 22510183 — intervention group
Group type: COMPARATOR
Intervention: SABER‐Placebo
Number of subjects: 124
Study 20448126 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg (ATOR40)
Number of subjects: 102
Study 20448126 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg (ATOR10)
Number of subjects: 102
Study 18500419 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane via Anaesthetic Conserving Device (ACD)
Number of subjects: 70